Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04263779 · ClinicalTrials.gov registry record · NA
Repisodic & Skilled Nursing Facility Preferred Provider Networks
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 5,581
- Enrollment target
NCT04263779: Completed NA study, sponsored by Geisinger Clinic.
NCT04263779 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 5,581 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (298% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04263779, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,581 participants
- Enrollment target
Study Summary
This study tests whether changing the relative order of presentation of post acute care skilled nursing facilities (SNFs) in the Repisodic application, i.e., presenting preferred SNFs (P-SNFs) first, increases selection of, and discharges to, P-SNFs and decreases lengths of stay (LoS) for Geisinger patients discharged to SNFs. Along with the order of P-SNFs, the study also assesses whether a short video reviewing the benefits of care coordination in P-SNFs increases patient election to transfer to one.
Primary Outcome
Difference in LoS (in days) for patients as a function of case manager study condition.
Interventions
- BEHAVIORAL Default Option
- BEHAVIORAL Order of Options
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,581 participants |
| Start Date | 2021-05-28 |
| Est. Completion | 2023-01-02 |
| Phase | NA |
What the finished NCT04263779 record still lists
NCT04263779 is an interventional study that assigns participants to a tested intervention. Its 5,581 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (298% higher).
The record links to 0 conditions, and to 2 interventions - of which Default Option is the first listed.
NCT04263779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04263779 about?
NCT04263779 is a clinical study titled "Repisodic & Skilled Nursing Facility Preferred Provider Networks". This study tests whether changing the relative order of presentation of post acute care skilled nursing facilities (SNFs) in the Repisodic application, i.e., presenting preferred SNFs (P-SNFs) first, increases selection of, and discharges to, P-SNFs and decreases lengths of stay (LoS) for Geisinger ...
What is the current status of trial NCT04263779?
This trial is currently completed. It is a NA study. The enrollment target is 5,581 participants. The study started on 2021-05-28. Estimated completion is 2023-01-02.
What interventions are being tested in trial NCT04263779?
The interventions under investigation include: Default Option (BEHAVIORAL), Order of Options (BEHAVIORAL).
Who is sponsoring clinical trial NCT04263779?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04263779's enrollment target sits among peer trials
5,581 24th of 2000 higher than 1,977 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06981598 · 5,586 participants · NA
Prevention of Psychological Health Problems Via Integrated Operational Support
- NCT05636176 · 5,600 participants · Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
- NCT06627335 · 5,621 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- NCT07146568 · 5,515 participants · NA
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI